129 related articles for article (PubMed ID: 9081965)
1. Lean (underweight) NIDDM - peculiarities and differences in metabolic and hormonal status - a pilot study.
Das S; Samal KC; Baliarsinha AK; Tripathy BB
J Assoc Physicians India; 1995 May; 43(5):339-42. PubMed ID: 9081965
[TBL] [Abstract][Full Text] [Related]
2. Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.
Chung JW; Suh KI; Joyce M; Ditzler T; Henry RR
Diabetes Care; 1995 May; 18(5):666-73. PubMed ID: 8586004
[TBL] [Abstract][Full Text] [Related]
3. Clinical profile of lean NIDDM in South India.
Mohan V; Vijayaprabha R; Rema M; Premalatha G; Poongothai S; Deepa R; Bhatia E; Mackay IR; Zimmet P
Diabetes Res Clin Pract; 1997 Nov; 38(2):101-8. PubMed ID: 9483373
[TBL] [Abstract][Full Text] [Related]
4. Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM.
Anfossi G; Mularoni EM; Burzacca S; Ponziani MC; Massucco P; Mattiello L; Cavalot F; Trovati M
Diabetes Care; 1998 Jan; 21(1):121-6. PubMed ID: 9538982
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus.
Park SW; Ihm SH; Yoo HJ; Park JY; Lee KU
Diabetes Res Clin Pract; 1997 Sep; 37(3):165-71. PubMed ID: 9306037
[TBL] [Abstract][Full Text] [Related]
6. Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus.
Vaag A; Henriksen JE; Madsbad S; Holm N; Beck-Nielsen H
J Clin Invest; 1995 Feb; 95(2):690-8. PubMed ID: 7860750
[TBL] [Abstract][Full Text] [Related]
7. NIDDM in the elderly.
Meneilly GS; Elliott T; Tessier D; Hards L; Tildesley H
Diabetes Care; 1996 Dec; 19(12):1320-5. PubMed ID: 8941457
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM.
Cusi K; Cunningham GR; Comstock JP
Diabetes Care; 1995 Jun; 18(6):843-51. PubMed ID: 7555511
[TBL] [Abstract][Full Text] [Related]
9. Difference in the influence of maternal and paternal NIDDM on pancreatic beta-cell activity and blood lipids in normoglycaemic non-diabetic adult offspring.
Kasperska-Czyzyk T; Jedynasty K; Bowsher RR; Holloway DL; Stradowska I; Stepień K; Nowaczyk R; Szymczak W; Czyzyk A
Diabetologia; 1996 Jul; 39(7):831-7. PubMed ID: 8817108
[TBL] [Abstract][Full Text] [Related]
10. Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.
Rachman J; Payne MJ; Levy JC; Barrow BA; Holman RR; Turner RC
Diabetes Care; 1998 May; 21(5):810-6. PubMed ID: 9589246
[TBL] [Abstract][Full Text] [Related]
11. Effect of high carbohydrate intake on hyperglycemia, islet function, and plasma lipoproteins in NIDDM.
Garg A; Grundy SM; Koffler M
Diabetes Care; 1992 Nov; 15(11):1572-80. PubMed ID: 1468287
[TBL] [Abstract][Full Text] [Related]
12. Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus--"Flatbush diabetes".
Banerji MA
J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():493-501. PubMed ID: 12017222
[TBL] [Abstract][Full Text] [Related]
13. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
[TBL] [Abstract][Full Text] [Related]
14. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM.
Kobayashi T; Nakanishi K; Murase T; Kosaka K
Diabetes; 1996 May; 45(5):622-6. PubMed ID: 8621013
[TBL] [Abstract][Full Text] [Related]
15. Day-long integrated serum insulin and C-peptide profiles in patients with NIDDM. Correlation with urinary C-peptide excretion.
Garvey WT; Olefsky JM; Rubenstein AH; Kolterman OG
Diabetes; 1988 May; 37(5):590-9. PubMed ID: 3282946
[TBL] [Abstract][Full Text] [Related]
16. Abnormalities of islet B-cell function, insulin action, and fat distribution in women with histories of gestational diabetes: relationship to obesity.
Ward WK; Johnston CL; Beard JC; Benedetti TJ; Porte D
J Clin Endocrinol Metab; 1985 Dec; 61(6):1039-45. PubMed ID: 3902865
[TBL] [Abstract][Full Text] [Related]
17. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men.
Chen KW; Boyko EJ; Bergstrom RW; Leonetti DL; Newell-Morris L; Wahl PW; Fujimoto WY
Diabetes Care; 1995 Jun; 18(6):747-53. PubMed ID: 7555498
[TBL] [Abstract][Full Text] [Related]
18. Comparison of different insulin regimens in elderly patients with NIDDM.
Wolffenbuttel BH; Sels JP; Rondas-Colbers GJ; Menheere PP; Nieuwenhuijzen Kruseman AC
Diabetes Care; 1996 Dec; 19(12):1326-32. PubMed ID: 8941458
[TBL] [Abstract][Full Text] [Related]
19. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.
Halberstam M; Cohen N; Shlimovich P; Rossetti L; Shamoon H
Diabetes; 1996 May; 45(5):659-66. PubMed ID: 8621019
[TBL] [Abstract][Full Text] [Related]
20. Plasma PAF acetylhydrolase in non-insulin dependent diabetes mellitus and obesity: effect of hyperinsulinemia and lovastatin treatment.
Kudolo GB; Bressler P; DeFronzo RA
J Lipid Mediat Cell Signal; 1997 Nov; 17(2):97-113. PubMed ID: 9459136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
